General Information of the Compound
Compound ID
CP0257977
Compound Name
2,2-Dimethyl-dodecanoic acid (2,4,6-trimethoxy-phenyl)-amide
    Show/Hide
Synonyms
114289-47-3
2,2-Dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide
2,2-Dimethyl-dodecanoic acid (2,4,6-trimethoxy-phenyl)-amide
8653IQ20EA
AC1L3UE4
ACMC-1CUXF
AKOS022180044
BDBM50005944
BN0150
BRN 5831010
C23H39NO4
CCG-222163
CHEBI:95040
CHEMBL22373
CI 976
CI-976
CTK4A8660
DTXSID00150690
Dodecanamide, 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)-
Dodecanamide,2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)-
HMS3262L19
HMS3268D10
LP00859
MolPort-002-018-232
PD 128042
SCHEMBL691688
Tox21_500859
UNII-8653IQ20EA
ZINC8022586
    Show/Hide
Structure
Formula
C23H39NO4
Molecular Weight
393.568
Canonical SMILES
CCCCCCCCCCC(C)(C)C(=O)Nc1c(OC)cc(OC)cc1OC
    Show/Hide
InChI
InChI=1S/C23H39NO4/c1-7-8-9-10-11-12-13-14-15-23(2,3)22(25)24-21-19(27-5)16-18(26-4)17-20(21)28-6/h16-17H,7-15H2,1-6H3,(H,24,25)
    Show/Hide
InChIKey
WAFNZAURAWBNDZ-UHFFFAOYSA-N
CAS
114289-47-3
Physicochemical Property
logP
6.2079
Rotatable Bonds
14
Heavy Atom Count
28
Polar Areas
56.79
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
28

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 122327
SID: 14903215
ChEMBL ID
CHEMBL22373
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT03513, Sterol O-acyltransferase 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000158 J774 Mus musculus (Mouse)  1
1
IC50 = 310 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( CI-976 )
Drug Name CI-976
Indication
Hyperlipidaemia
Discontinued in Phase 2
Target(s)
Liver carboxylesterase (CES1)
Inhibitor